Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

QPS cardiac collaboration to extend sponsor networks

29-Sep-2016 - QPS Holdings LLC  and G-CURE BV  will collaborate on cardiovascular drug development programs for pharmaceutical companies.

Charles River continues CRO buy up, acquires Agilux Labs for $64m

29-Sep-2016 - Charles River Laboratories has acquired Worcester, MA-based contract research organization (CRO) Agilux Laboratories, further bolstering the company’s early-stage services.

CRO Pharmaron and MSD reach shared site agreement

27-Sep-2016 - Pharmaron has acquired MSD’s Hoddesdon, UK-based Good Manufacturing Practice (GMP) standard facilities to advance its API and formulation development.

News in brief

Alcami enhances analytical services in Edison, NJ

27-Sep-2016 - The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.

News in brief

Crown Bio launches new feature for XenoBase in vitro models

22-Sep-2016 - Crown Bioscience has published an updated version of its XenoBase, an online database collating cell line and cell line derived xenograft model data.

Plasticell and CellSpring collaborate on high performance drug screening

20-Sep-2016 - The collaboration combines Plasticell’s cell culture media for creating fat and bone cells in 2-dimensional cell cultures, with CellSpring’s high throughput 3-dimensional screening assays for drug discovery.

Drug development consultancy Certara focusing on 'value based development'

19-Sep-2016 - Through its acquisition of d3 Medicine, Certara has expanded its Strategic Consulting (CSC) division, which uses a range of methods to support drug development.

Fragile X drug developer Fulcrum to use Horizon's CRISPR to find gene targets

15-Sep-2016 - Fulcrum Therapeutics will use a CRISPR gene editing-based platform to identify genetic targets under a deal with Horizon Discovery Group.

Brexit revisited: focusing on 'the war on talent'

06-Sep-2016 - More than two months after Britain decided to leave the EU, companies reevaluate the state of business and what comes next, specifically for jobs within the industry.

NIH human-animal chimera research under debate, experts weigh in

02-Sep-2016 - As stem cell and gene editing technologies become more advanced, researchers are increasingly interested in growing human tissues and organs in animals – but what are the implications of human-animal chimeras?

Cheminformatics company provides researchers with access to more than 700,000 chemicals

29-Aug-2016 - ACD/Labs’ flagship product ACD/ChemSketch allows pharmaceutical scientists to “better understand the fate of molecules,” says the company president.

Metrion: research consortium aiming to reduce animal studies, facilitate new drug development

25-Aug-2016 - Metrion Biosciences (Metrion), an ion-channel and drug discovery CRO, has joined a network of partners to evaluate the use of primary human dorsal root ganglion (hDRG) neurons in pain research.

AMRI partners to advance RNA-based therapeutics, research tools

24-Aug-2016 - AMRI and the University at Albany’s RNA Institute are partnering to speed the development of new RNA-based therapeutics in an “ideal and first of its kind” collaboration.


AMRI licenses CRISPR-Cas9 gene editing tech for drug discovery

23-Aug-2016 - AMRI has entered into an agreement to license CRISPR-Cas9 gene editing technology from the Broad Institute of MIT and Harvard.

Crown Bio adds services at newly expanded oncology center

16-Aug-2016 - Crown Bioscience has expanded its oncology services with new models, cell lines, and assays at its San Diego-based Center of Excellence for Oncology.

Charles River partners with Milner Therapeutics Institute and Consortium

09-Aug-2016 - Charles River Laboratories has entered into a strategic partnership with the Milner Therapeutics Institute and Consortium and will provide the organization with access to its resources and services.

Sekisui XenoTech expands hepatotoxicity testing services

09-Aug-2016 - The global contract research organization (CRO) is increasing its focus on hepatotoxicity, one of the leading causes of adverse events in clinical trials.


Envigo on the responsible use of animal research

05-Aug-2016 - Envigo recently announced the two of its sites have earned accreditation from the lab animal treatment watchdog, AAALAC.

Biologics and biosimilar services drive Q2 sales boost for CRL

04-Aug-2016 - Charles River says it is capitalising on the growing number of biologics in development, with its manufacturing business seeing double-digit growth led by demand for biosafety and cell banking services....

Open-source drug discovery project advances drug development

29-Jul-2016 - The first of its kind trial has successfully identified several compounds to pursue and has given rise to more than a dozen drug development projects.

CrownBio expands US operations

27-Jul-2016 - Crown Bioscience has expanded its San Diego facility to create its US Center of Excellence for Oncology in order to support increasing demand for oncology research studies.

Questions surrounding Indian CRO result in medicine suspension recommendation

22-Jul-2016 - The EMA is recommending the suspension of several medicines after inspections revealed flawed studies at the India-based contract research organization (CRO), Semler Research Centre.

Mitsubishi Tanabe licenses simulation tech

21-Jul-2016 - Mitsubishi Tanabe has joined the Simcyp Consortium – gaining a license to the modeling and simulation group’s pharmacokinetic prediction technology.

Exco InTouch approved fully compliant with NIST guidelines

20-Jul-2016 - Exco InTouch has completed a HIPAA Privacy audit as the company continues to prepare for impending data protection regulations.

Envigo facilities earn AAALAC accreditation

20-Jul-2016 - Envigo has announced that its sites in Bresso, Italy and Wyton, UK have earned their accreditation from the lab animal treatment watchdog, AAALAC.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...